Paris, France

Etienne Prugnard

This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Etienne Prugnard. Retrieved from https://idiyas.com/inventor/etienne-prugnard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Etienne Prugnard: Innovator in Pharmaceutical Chemistry

Introduction

Etienne Prugnard is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on thiazolidone derivatives.

Latest Patents

Prugnard holds a patent for "Thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same." This patent showcases his expertise in developing new pharmaceutical compounds that could have important applications in medicine. He has 1 patent to his name.

Career Highlights

Etienne Prugnard is associated with Merck Patent Gesellschaft mit beschränkter Haftung, a leading company in the pharmaceutical industry. His work at Merck has allowed him to focus on innovative research and development in drug formulation and synthesis.

Collaborations

Throughout his career, Prugnard has collaborated with esteemed colleagues such as Gérard Moinet and Gérard Botton. These collaborations have further enriched his research and contributed to advancements in pharmaceutical sciences.

Conclusion

Etienne Prugnard is a distinguished inventor whose work in pharmaceutical chemistry continues to impact the industry. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…